Menu

Neos Therapeutics, Inc. NEOS

Full chart Compare
Set alert

Price alert · NEOS

All alert types

No live quote for NEOS yet.

Revenue & Expenses

Revenue by
Adzenys Product → Revenue: $31.21MRevenue → Gross Profit: $39.53MGross Profit → Expenses: $39.53MRevenue → Cost of Revenue: $25.12MExpenses → Selling, General & Admin: $41.36MExpenses → Research & Development: $8.58MExpenses → Other Expenses: $6.48MExpenses → Income Tax: $11.00KCotempla Xr Odt → Revenue: $25.65MNet Loss → Expenses: $16.90MGeneric Tussionex Product → Revenue: $6.95MAdzenys Er → Revenue: $834.00KGross Profit$39.53MNet Loss$16.90MCost of Revenue$25.12MExpenses$56.43MSelling, General & Admin$41.36MResearch & Development$8.58MOther Expenses$6.48MIncome Tax$11.00KRevenue$64.65MAdzenys Product$31.21MCotempla Xr Odt$25.65MGeneric Tussionex Product$6.95MAdzenys Er$834.00K

Latest period ending Dec 31, 2019 · select a line to chart its full history

NEOS annual income statement
Fiscal yearFY 2019 Dec 31, 2019FY 2018 Dec 31, 2018FY 2017 Dec 31, 2017FY 2016 Dec 31, 2016FY 2015 Dec 31, 2015
64.65M49.99M27.13M10.03M3.79M
39.53M23.06M13.10M-1.70M-2.14M
-10.41M-43.50M-56.54M-75.82M-26.58M
-16.90M-51.67M-65.77M-82.75M-30.78M
-0.34-1.60-2.66-5.16-4.38
NEOS annual balance sheet
Fiscal yearFY 2019 Dec 31, 2019FY 2018 Dec 31, 2018FY 2017 Dec 31, 2017FY 2016 Dec 31, 2016FY 2015 Dec 31, 2015
16.83M46.48M31.97M24.35M90.76M
90.87M111.36M104.11M80.14M122.51M
97.00M103.51M95.16M81.69M44.14M
48.87M51.77M59.83M63.52M34.24M
-6.13M7.84M8.95M-1.55M78.37M
NEOS annual cash flow
Fiscal yearFY 2019 Dec 31, 2019FY 2018 Dec 31, 2018FY 2017 Dec 31, 2017FY 2016 Dec 31, 2016FY 2015 Dec 31, 2015
-10.78M-41.44M-53.26M-70.65M-25.87M
-9.12M17.22M-2.53M-19.32M1.98M
-9.75M38.73M63.41M23.56M101.31M
-1.09M-1.36M-2.50M-3.55M-1.02M
-29.65M14.51M7.62M-66.41M77.42M